Resteghini, Carlo
Trama, Annalisa
Borgonovi, Elio
Hosni, Hykel
Corrao, Giovanni
Orlandi, Ester
Calareso, Giuseppina
De Cecco, Loris
Piazza, Cesare
Mainardi, Luca
Licitra, Lisa
Article History
First Online: 25 October 2018
Compliance With Ethical Standards
:
: Carlo Resteghini declares that he has no conflict of interest.Annalisa Trama declares that she has no conflict of interest.Elio Borgonovi declares that he has no conflict of interest.Hykel Hosni declares that he has no conflict of interest.Giovanni Corrao has received research funding through grants from the European Community (EC); the Italian Medicines Agency (AIFA); the Italian Ministry of Education, Universities and Research (MIUR); Novartis; GlaxoSmithKline; Roche; Amgen; and Bristol-Myers Squibb.Ester Orlandi declares that she has no conflict of interest.Giuseppina Calareso declares that she has no conflict of interest.Loris De Cecco has received research funding from the Associazione Italiana Ricerca Cancro (AIRC).Cesare Piazza declares that he has no conflict of interest.Luca Mainardi declares that he has no conflict of interest.Lisa Licitra has received funding (to her institution) for clinical studies and research from AstraZeneca, Boehringer Ingelheim, Eisai, Merck Serono, MSD, Novartis, and Roche; has received compensation for service as a consultant/advisor and/or for lectures from AstraZeneca, Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Debiopharm, Eisai, Merck Serono, MSD, Novartis, Roche, and Sobi; and has received travel coverage for medical meetings from Bayer, Bristol-Myers Squibb, Debiopharm, Merck Serono, MSD, and Sobi.
: This article does not contain any studies with human or animal subjects performed by any of the authors.